Two-phase product with ethyl lauroyal arginate HCL

Abstract

A two-phase product.

Description

[0001] The present invention relates to a cosmetic two-phase product comprising ethyl lauroyal larginate HCL.

[0002] Cosmetic products generally serve not only to make one look beautiful and attractive, but also contribute significantly to increased self-esteem and well-being. Consumers often apply decorative cosmetics to improve their appearance. However, these products are removed from the skin in the evening before going to bed. Cosmetic cleansing products are used for this removal; these products offer particularly effective cleansing without causing skin irritation.

[0003] A typical category of these cleaning products are cosmetic two-phase products, which are mixed by shaking before use. After use, the products separate within a short time. The presence of two separate phases is indicated to the consumer, for example, by the different colors of the phases. They consist of a specific proportion of an oil phase and a water phase.

[0004] In the area of ​​cleansing products, it has been shown that two-phase systems offer better cleaning performance, especially with waterproof makeup. Here, the effective cleansing action of oils is combined with water, which minimizes the oily residue.

[0005] To form a two-phase product, a phase containing water and a phase containing oil are required. At rest, these two phases are clearly distinguishable. Due to their different densities, these two phases do not mix spontaneously and thus form a horizontally separated two-phase system. By introducing energy, for example by shaking, the phases can be briefly mixed. However, due to the density difference and the high interfacial tension (IFS) of oil compared to water, a very rapid separation back into the two phases occurs.

[0006] To use two-phase products correctly, the separation rate, and especially the start of the separation process, should ideally be slowed down. Otherwise, only one phase, or mostly only one phase, can be extracted and used. This means that if the phases are separated immediately after shaking, sometimes only one phase can be extracted, and cleaning is done, for example, with water. This results in reduced cleaning performance because the cleaning effect of the oil is lacking.

[0007] The products currently on the market either accept that the separation is too rapid or attempt to solve the problem by adding surfactants or emulsifiers. While these additives reduce the surface tension, they can also lead to cloudiness or precipitation in the preparation.

[0008] Among other things, EP 2732805 A1 discloses that by adding short-chain dimethicones (such as Belsil DM 10 from Wacker), the two-phase preparation can be optimized to such an extent that the product is again present in two clear phases after some time, which is particularly important for the consumer. Furthermore, the invention of EP 2732805 A1 also consists in the fact that, by adding benzethonium chloride, the two-phase products exhibit an optically clear separation.

[0009] However, consumers are increasingly avoiding products containing silicone components. Furthermore, benzethonium chloride is a chemical disinfectant suspected of triggering allergies. This suspicion, however, has not been confirmed. Ultimately, the ongoing controversy surrounding this issue also leads consumers to avoid products containing benzethonium chloride.

[0010] Consequently, alternative approaches are needed that make it possible to obtain separate phases with high transparency. In particular, the object of the invention was to provide means and measures that make it possible to obtain a particularly transparent oil phase after separation.

[0011] The present invention provided a surprising solution to the problem.

[0012] The invention is a two-phase cosmetic or dermatological preparation comprising a horizontally separated two-phase system comprising an oil and an aqueous phase, characterized in that the preparation comprises ethyl lauroyal larginate HCL.

[0013] Surprisingly, the addition of ethyl lauroyal arginate HCl resulted in significantly more transparent oil phases, provided the two-phase product had been allowed to stand for 12 hours. This effectively prevented turbidity caused by the two phases in the product. Particularly surprising was the fact that even at low salt concentrations, exceptionally transparent oil phases were obtained after a 12-hour standstill.

[0014] The term "transparent" here refers to a transmission measurement at 25°C at 880 nm. The higher the transmission, the more transparent the system.

[0015] Unless otherwise stated, all tests and measurements were performed under "normal conditions". "Normal conditions" refers to 20°C, 1013 hPa, and 50% relative humidity.

[0016] The term "skin" refers exclusively to human skin.

[0017] Where weight percentages (wt%) are given below without reference to a specific composition or mixture, these percentages always refer to the total weight of the preparation. Where ratios of components / substances / groups of substances are disclosed below, these ratios refer to the weight ratios of the components / substances / groups of substances mentioned.

[0018] Where weight percentage ranges for the components of the preparation are specified below, the disclosure of the present application also includes all individual values ​​in steps of 0.1 wt.% within these weight percentage ranges.

[0019] The terms “according to the invention”, “advantageous according to the invention”, “advantageous in the sense of the present invention”, etc., always refer, within the scope of the present disclosure, to the preparation according to the invention as well as the use according to the invention and the method.

[0020] For the purposes of this disclosure, the term "free from" means that the proportion of the substance in question does not exceed 0.1% by weight and, in particular, is 0% by weight of the total weight of the preparation. Thus, accidental introduction through impurities should not lead to exclusion from the scope of protection.

[0021] Emulsifiers are defined as all substances listed as "emulsifying agents" in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010 (ISBN 1-882621-47-6). Surfactants are defined as all substances listed as "surfactants" in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010 (ISBN 1-882621-47-6).

[0022] Any viscosity values ​​given in this disclosure refer to measurements taken at 25°C in a 150 ml wide-mouth bottle (VWR No.: 807-0001) using the Rheomat R 123 from proRheo GmbH. The Rheomat R 123 is a rotational viscometer, meaning that a measuring element rotates within the substance being measured. The force required to rotate the measuring element within the sample at a predetermined speed is measured. The viscosity is then calculated from this torque, the rotational speed of the measuring element, and the geometric dimensions of the measuring system. The measuring element used is No. 1 (article no. 200 0191), suitable for a viscosity range up to 10,000 mPa·s and a rotational speed of 62.5 min⁻¹.

[0023] When this disclosure refers to an average, that average always refers to arithmetic means.

[0024] Any information regarding the molecular weight of polymers given in this disclosure refers to a measurement by means of light scattering.

[0025] Advantageously, ethyl lauroyal arginate HCL is used in the range of 0.0001 to 1 wt.%, preferably from 0.0005 to 0.1 wt.% and particularly preferably from 0.001 to 0.05 wt.%, based on the total mass of the preparation.

[0026] According to the invention, it is advantageous if the total proportion of the oil phase is 30 to 70 wt.%, preferably 35 wt.%, up to 65 wt.%, preferably 40 to 60 wt.%, preferably 45 to 55 wt.% and in particular 47.5 to 52.5 wt.%, based on the total weight of the preparation.

[0027] The oil phase of the preparation according to the invention advantageously comprises one or more oils selected from the group consisting of isododecane, isohexadecane, isopropyl palmitate, C9-12 alkanes, C13-15 alkanes, C15-19 alkanes, triheptanoin, C13-16 isoalkanes, and coco-caprylate / caprate.

[0028] It is generally advantageous if the total proportion of oils selected from the group consisting of isododecane, isohexadecane, isopropyl palmitate, C9-12 alkanes, C13-15 alkanes, C15-19 alkanes, triheptanoin, C13-16 isoalkanes, and coco-caprylate / caprate is 19 to 61 wt.%, preferably 24 to 51 wt.%, preferably 30 to 45 wt.%, and particularly preferably 35 to 40 wt.%, in each case based on the total weight of the preparation.

[0029] It is advantageous if isododecane is included. If the oil phase comprises isododecane, it is advantageous if the total isododecane content is 20 to 60 wt.%, preferably 25 to 50 wt.%, preferably 27 to 48 wt.%, preferably 30 to 45 wt.%, and particularly preferably 35 to 40 wt.%, in each case based on the total weight of the preparation.

[0030] It is advantageous if isohexadecane is included. If the oil phase comprises isohexadecane, it is advantageous if the total proportion of isohexadecane is 2 to 35 wt.%, preferably 3 to 30 wt.%, preferably 4 to 25 wt.%, preferably 5 to 18 wt.%, and particularly preferably 6 to 12 wt.%, in each case based on the total weight of the preparation.

[0031] It is advantageous if isopropyl palmitate is included. If the oil phase comprises isopropyl palmitate, it is advantageous if the total proportion of isopropyl palmitate is 0.1 to 10 wt.%, preferably 0.5 to 7.5 wt.%, more preferably 0.7 to 3.0 wt.%, more preferably 0.9 to 2.0 wt.%, and particularly preferably 1.0 to 1.5 wt.%, in each case based on the total weight of the preparation.

[0032] It is advantageous if C15-19 alkanes are present. If the oil phase comprises C15-19 alkanes, it is advantageous if the total proportion of C15-19 alkanes is 0.1 to 15 wt.%, preferably 1.5 to 12.5 wt.%, preferably 3.0 to 10 wt.%, preferably 4.0 to 9.0 wt.%, and particularly preferably 5.0 to 8.5 wt.%, in each case based on the total weight of the preparation.

[0033] It is advantageous if coco-caprylate / caprate is included. If the oil phase comprises coco-caprylate / caprate, it is advantageous if the total proportion of coco-caprylate / caprate is 0.1 to 10 wt.%, preferably 0.5 to 8.5 wt.%, more preferably 0.8 to 6.5 wt.%, more preferably 1.3 to 5.0 wt.%, and particularly preferably 1.8 to 3.5 wt.%, in each case based on the total weight of the preparation.

[0034] Furthermore, it is advantageous if the oil phase contains one or more colorants. Colorants advantageously included in the oil phase are selected from the group containing CI 61565, CI 60725, Haematococcus Pluvialis, and CI 75130.

[0035] Preferred embodiments of the invention are further advantageously characterized in that they are free of silicone oils and / or silicone components. By definition, silicone components are understood to be liquid substances under normal conditions that contain an alkyl silicon group. "Free of" in this context means that these components are not present.

[0036] The aqueous phase of the preparation according to the invention advantageously comprises at least one non-ionic surfactant. Advantageously, the non-ionic surfactants contained in the aqueous phase are selected from the group consisting of alkyl glucosides and polyglyceryl esters.

[0037] According to the invention, advantageous alkyl glucosides are selected from the group consisting of decyl glucosides, caprylyl glucosides, capryl glucosides, caprylyl / capryl glucosides, lauryl glucosides and / or coco glucosides. It is particularly advantageous if caprylyl / capryl glucosides are included.

[0038] If at least one alkyl glucoside is included, it is preferred that the total proportion of alkyl glucosides is 0.01 to 1 wt.%, preferably 0.05 to 0.2 wt.% and particularly preferably 0.06 to 0.13 wt.%, based on the total weight of the preparation.

[0039] If at least one alkyl glucoside selected from the group consisting of decyl glucosides, caprylyl glucosides, capryl glucosides, caprylyl / capryl glucosides, lauryl glucosides and / or coco glucosides is included, it is preferred that the total proportion of these alkyl glucosides is 0.01 to 1 wt.%, preferably 0.05 to 0.2 wt.% and particularly preferably 0.06 to 0.13 wt.%, based on the total weight of the preparation.

[0040] If caprylyl / capryl glucoside is included, it is preferred that the total proportion of caprylyl / capryl glucoside is 0.01 to 1 wt.%, preferably 0.05 to 0.2 wt.% and particularly preferably 0.06 to 0.13 wt.%, based on the total weight of the preparation.

[0041] According to the invention, polyglyceryl esters are understood to be esters formed from polyglycerol (for example, polyglycerol-10) and at least one fatty acid. Polyglycerol is understood to be a polymer of glycerol, wherein the polymer is formed from at least two glycerol monomers. Fatty acids are understood to be aliphatic monocarboxylic acids having at least 10 carbon atoms.

[0042] Polyglyceryl esters that are advantageous according to the invention are selected from the group of polyglyceryl-3 caprylates, polyglyceryl-4 caprylates, polyglyceryl-6 caprylates, polyglyceryl-10 laurates, polyglyceryl-6 stearates, polyglyceryl-6 behenates and polyglyceryl-10 stearates.

[0043] If at least one polyglyceryl ester is included, it is preferred that the total proportion of polyglyceryl esters is 0.01 to 1 wt.%, preferably 0.05 to 0.2 wt.% and particularly preferably 0.06 to 0.13 wt.%, based on the total weight of the preparation.

[0044] If at least one polyglyceryl ester selected from the group consisting of polyglyceryl-3 caprylate, polyglyceryl-4 caprylate, polyglyceryl-6 caprylate, polyglyceryl-10 laurate, polyglyceryl-6 stearate, polyglyceryl-6 behenate and polyglyceryl-10 stearate is included, it is preferred that the total proportion of the polyglyceryl esters selected from this group is 0.01 to 1 wt.%, preferably 0.05 to 0.2 wt.% and particularly preferably 0.06 to 0.13 wt.%, based on the total weight of the preparation.

[0045] According to the invention, it is advantageous if the preparation is free of benzethonium chloride. Accordingly, the preparation advantageously contains no benzethonium chloride.

[0046] Furthermore, it is advantageous within the meaning of the present invention if the preparation is characterized in that it comprises trisodium EDTA. If trisodium EDTA is included, it is advantageous if the total proportion of trisodium EDTA is between 0.01 and 0.4% by weight, based on the total weight of the preparation.

[0047] Furthermore, it is advantageous within the meaning of the present invention if the preparation is characterized in that it comprises trisodium EDTA. If trisodium EDTA is included, it is advantageous if the total proportion of trisodium EDTA is between 0.01 and 0.4% by weight, based on the total weight of the preparation.

[0048] Furthermore, it is advantageous within the meaning of the present invention if the preparation is characterized in that it comprises EDDS (ethylenediamine succinic acid) or its salts. If EDDS and / or its salts are included, it is advantageous if the total proportion of EDDS and / or its salts is 0.01 to 0.2% by weight, based on the total weight of the preparation.

[0049] Furthermore, it is advantageous in the context of the present invention if the preparation is characterized by comprising glycerin. If glycerin is included, it is advantageous if it is present in a proportion of 0.1 to 10 wt.%, preferably 1.0 to 3.5 wt.%, and particularly preferably 1.5 to 2.5 wt.%, based on the total weight.

[0050] Furthermore, it is advantageous in the context of the present invention if the preparation is characterized by comprising glycerin. If glycerin is included, it is advantageous if it is present in a proportion of 0.1 to 5 wt.%, preferably 1.0 to 3.5 wt.%, and particularly preferably 1.5 to 2.5 wt.%, based on the total weight.

[0051] Furthermore, it is advantageous within the meaning of the present invention if the preparation is characterized in that it comprises sodium chloride. If sodium chloride is included, it is advantageous if the sodium chloride is present in a proportion of 0.1 to 1.0 wt.%, preferably 0.15 to 0.5 wt.%, and particularly preferably 0.2 to 0.4 wt.%, based on the total weight.

[0052] Furthermore, it is advantageous in the context of the present invention if the preparation is characterized by comprising phenoxyethanol. If phenoxyethanol is included, it is advantageous if it is present in a proportion of 0.1 to 1.0 wt.%, preferably 0.15 to 0.5 wt.%, and particularly preferably 0.2 to 0.4 wt.%, based on the total weight.

[0053] Furthermore, it is advantageous if the water phase comprises water. If water is included, it is further advantageous if the total water content, based on the total weight of the water phase, is more than 80 wt.%, preferably more than 90 wt.%, preferably more than 92 wt.%, preferably more than 94 wt.%, preferably more than 96 wt.%, and less than 98 wt.%.

[0054] Furthermore, it is advantageous if the aqueous phase of the preparation includes one or more water-soluble dyes, in particular CI 16035 (FD&C Red 40; 6-Hydroxy-5-((6-methoxy-4-sulfo-m-tolyl)azo)-2-naphthalenesulfonic acid disodium salt).

[0055] Another noteworthy factor with two-phase products is their filling ratio. Finding the right balance between the water and oil phases proved crucial for optimal cleaning performance. Too little oil negatively impacts cleaning efficiency.

[0056] Ideally, the weight ratio of the water phase to the oil phase is chosen to be in the range of 4:1 to 2:3, advantageously from 7:3 to 1:1.4, and particularly from 1.2:1 to 1:1.2.

[0057] Since two-phase preparations are frequently used as cleansing agents and especially as eye makeup removers, very good tolerability is particularly important in the area around the eye. This is achieved by the preparation according to the invention.

[0058] Advantageously, the preparations according to the invention comprise less than 0.01 wt.%, in particular 0 wt.%, of polymers and / or thickeners, in each case based on the total mass of the preparation.

[0059] The production of the two-phase preparations according to the invention can advantageously proceed as shown below by way of example.

[0060] The following are preferred manufacturing options:

[0061] Water phase: 1. Aqua Mix raw materials until clear / completely dissolved! 2. Phenoxyethanol 3. Ethyl lauroyal arginate HCL 4. Trisodium EDTA Add and stir 5. Sodium Chloride Add and stir 6. Decyl Alcohol Add and stir 7. Caprylyl Alcohol Add and stir 8. Glycerin Add and stir 9. Biotin Add and stir 10. Caprylyl / Capryl Glucoside Add last and stir! Oil phase: 1. Isododecane Mix raw materials until clear / completely dissolved! 2. C15-19 Alkanes 3. Isopropyl Palmitate 4. Coco-Caprylate / Caprate 5. CI 61565 Add and stir 6. CI 60725 Add and stir

[0062] The following manufacturing process is also advantageous: Water phase: 1. Trisodium EDTA Mix raw materials until clear / completely dissolved! 2. Ethyl lauroyal arginate HCL 3. Aqua 4. Phenoxyethanol Add and stir 5. Sodium Chloride Add and stir 6. Caprylyl / Capryl Glucoside Add last and stir! or 1. Ethyl lauroyal arginate HCL Mix raw materials until clear / completely dissolved! 2. Aqua 3. Phenoxyethanol 4. Trisodium EDTA Add and stir 5. Sodium Chloride Add and stir 6. Caprylyl / Capryl Glucoside Add last and stir! or 1. Aqua Mix raw materials until clear / completely dissolved! 2. Glyceryl Glucoside 3. Glycerin 4. Phenoxyethanol 5. Ethyl lauroyal larginate HCL 6. Trisodium EDTA Add and stir 7. Sodium Chloride Add and stir 8. Caprylyl / Capryl Glucoside Add last and stir!

[0063] Oil phase: 1. Coco-Caprylate / Caprate Mix raw materials until clear / completely dissolved! 2. C15-19 Alkanes 3. Isododecane 4. CI 61565 Add and stir 5. CI 60725 Add and stir Examples

[0064] The following example recipes are intended to illustrate the present invention. Numerical values ​​refer to weight percentages based on the total mass of the preparation. Ingredients Example 1 Example 2 Water phase Aqua add 100 add to 100 Glycerin 1,93 1,93 Phenoxyethanol 0,26 0,26 Trisodium EDTA 0,09 0,09 Sodium Chloride 0,24 0,24 Caprylyl / Caprylglucoside 0,09 0,09 Biotin 0,01 0,01 Decyl Alcohol 0,0005 0,0005 Caprylyl Alcohol 0,0003 0,0003 Ethyl Lauroyl Arginate HCl 0,001 0 Oil phase Isododecane 38,8 38,8 C15-19 Alkanes 7,5 7,5 Coco-Caprylate / Caprate 2,5 2,5 isopropyl palmitate 1,2 1,2 Cl 61565 0,00035 0,00035 Cl 60725 0,00025 0,00025 Transmission of the oil phase 97,88% 69,66%

[0065] The oil and water phases were prepared separately, analogous to the description above. A total of 125 ml of the two-phase formula was prepared in a 125 ml PET bottle. The bottle containing the two-phase formula was vigorously shaken by hand 20 times to ensure complete mixing of the phases. After shaking, the bottle was left undisturbed for 12 hours. Subsequently, 20 ml of the upper oil phase were pipette-deposited from the bottle and transferred into standard 30 ml cylindrical Turbiscan vials. The transmission of the oil phase was measured in standard 30 ml cylindrical vials at a height of 30 mm from the bottom of the vial at a wavelength of 880 nm and 25 °C using MICROTRAC TURBISCAN AGS. A higher transmission value indicates a clearer oil phase.

[0066] Consequently, the invention allows clear oil phases to be obtained 12 hours after shaking.

[0067] Further example recipes: Ingredients Example 3 Example 4 Example 5 Water phase Aqua add 100 add to 100 add 100 Glycerin 2 2,5 2 Phenoxyethanol 0,26 0,26 0,26 EDDS 0 0 0,1 Trisodium EDTA 0,09 0,09 0 Sodium Chloride 0,24 0,24 0,3 Caprylyl / Caprylglucoside 0,09 0,09 0,09 Polyglyceryl-4 Caprylate 0 0 0 Biotin 0,01 0,01 0 Decyl Alcohol 0,0005 0,0005 0,0005 Caprylyl Alcohol 0,0003 0,0003 0,0003 Ethyl Lauroyl Arginate HCl 0,001 0,003 0,001 Cl 16035 0 0 0 Oil phase Isododecane 38,8 38,8 0 Isohexadecane 0 0 38,8 C15-19 Alkanes 7,5 7,5 7,5 Coco-Caprylate / Caprate 2,5 2,5 2,5 Isopropyl Palmitate 1,2 1,2 1,2 Cl 61565 0,00035 0,00035 0,00035 Cl 60725 0,00025 0,00025 0,00025 Inhaltstoffe Bsp. 6 Bsp. 7 Bsp. 8 Wasserphase Aqua add to 100 add to 100 Add to 100 Glycerin 2,5 4 2 Phenoxyethanol 0,26 0,3 0,26 EDDS 0,09 0 0,01 Trisodium EDTA 0 0,1 0,05 Sodium Chloride 0,2 0,5 0,24 Caprylyl / CaprylGlucoside 0,09 0,1 0 Polyglyceryl-4 Caprylate 0 0 0,1 Biotin 0 0 0 Decyl Alcohol 0,0005 0,0005 0,0005 Caprylyl Alcohol 0,0003 0,0003 0,0003 Ethyl Lauroyl ArginateHCl 0,003 0,05 0,002 Cl 16035 0 0,0003 0,0003 Ölphase Isododecane 0 30 38,7 Isohexadecane 40 10 0,1 C15-19 Alkane 7 6 7,5 Coco-Caprylate / Caprate 3 2 2,5 Caprylic / CapricTriglyceride 2 1 0 Isopropyl Palmitate 1,2 1 1,2 Cl 61565 0,00035 0 0,00035 Cl 60725 0,00025 0 0,00025 QUOTES INCLUDED IN THE DESCRIPTION

[0000] This list of documents cited by the applicant was automatically generated and is included solely for the reader's convenience. The list is not part of the German patent or utility model application. The DPMA accepts no liability for any errors or omissions. Cited patent literature

[0000] EP 2732805 A1

[0008] Cited non-patent literature

[0000] International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6

[0021]

Claims

[1] Two-phase cosmetic or dermatological preparation comprising a horizontally separated two-phase system comprising an oil phase and an aqueous phase, characterized by that the preparation includes ethyl lauroyal larginate HCL. [2] Preparation according to claim 1 characterized by , that ethyl lauroyal arginate HCL is contained in the range of 0.0001 to 1 wt.%, preferably from 0.0005 to 0.1 wt.% and particularly preferably from 0.001 to 0.05 wt.%, based on the total mass of the preparation. [3] Preparation according to any one of the preceding claims characterized by , that the total proportion of the oil phase is 30 to 70 wt.%, preferably 35 wt.%, to 65 wt.%, preferably 40 to 60 wt.%, preferably 45 to 55 wt.% and in particular 47.5 to 52.5 wt.%, based on the total weight of the preparation. [4] Preparation according to any one of the preceding claims characterized bythat one or more oils selected from the group consisting of isododecane, isohexadecane, isopropyl palmitate, C9-12 alkanes, C13-15 alkanes, C15-19 alkanes, triheptanoin, C13-16 isoalkanes, and coco-caprylate / caprate are included. [5] Preparation according to claim 4 characterized by , that the total proportion of oils selected from the group consisting of isododecane, isohexadecane, isopropyl palmitate, C9-12 alkanes, C13-15 alkanes, C15-19 alkanes, triheptanoin, C13-16 isoalkanes, and coco-caprylate / caprate is 19 to 61 wt.%, preferably 24 to 51 wt.%, preferably 30 to 45 wt.% and particularly preferably 35 to 40 wt.%, in each case based on the total weight of the preparation. [6] Preparation according to any one of the preceding claims characterized by, that the total proportion of isododecane is 20 to 60 wt.%, preferably 25 to 50 wt.%, preferably 27 to 48 wt.%, preferably 30 to 45 wt.% and particularly preferably 35 to 40 wt.%, in each case based on the total weight of the preparation. [7] Preparation according to any one of the preceding claims characterized by , that the oil phase comprises isopropyl palmitate and the total proportion of isopropyl palmitate is 0.1 to 10 wt.%, preferably 0.5 to 7.5 wt.%, preferably 0.7 to 3.0 wt.%, preferably 0.9 to 2.0 wt.% and particularly preferably 1.0 to 1.5 wt.%, in each case based on the total weight of the preparation. [8] Preparation according to any one of the preceding claims characterized by, that the oil phase comprises C15-19 alkanes and the total proportion of C15-19 alkanes is from 0.1 to 15 wt.%, preferably from 1.5 to 12.5 wt.%, preferably from 3.0 to 10 wt.%, preferably from 4.0 to 9.0 wt.% and particularly preferably from 5.0 to 8.5 wt.%, in each case based on the total weight of the preparation. [9] Preparation according to any one of the preceding claims characterized by that the oil phase comprises coco-caprylate / caprate and the total proportion of coco-caprylate / caprate is from 0.1 to 10 wt.%, preferably from 0.5 to 8.5 wt.%, preferably from 0.8 to 6.5 wt.%, preferably from 1.3 to 5.0 wt.% and particularly preferably from 1.8 to 3.5 wt.%, in each case based on the total weight of the preparation. [10] Preparation according to any of the preceding claims characterized by that one or more dyes selected from the group CI 61565, CI 60725, Haematococcus Pluvialis and CI 75130 are included. [11] Preparation according to any of the preceding claims characterized by that the preparation is free of silicone oils and / or silicone components. [12] Preparation according to any of the preceding claims characterized by that at least one alkyl glucoside is contained, wherein it is preferred that the total proportion of alkyl glucosides is from 0.01 to 1 wt.%, preferably from 0.05 to 0.2 wt.% and particularly preferably from 0.06 to 0.13 wt.%, based on the total weight of the preparation. [13] Preparation according to any of the preceding claims characterized by that a polyglyceryl ester is included, preferably if the total proportion of the polyglyceryl esters is 0.01 to 1 wt.%, preferably 0.05 to 0.2 wt.% and particularly preferably 0.06 to 0.13 wt.%, based on the total weight of the preparation. [14] Preparation according to any of the preceding claims characterized bythat the water phase comprises water and the total water content, based on the total weight of the water phase, is more than 80 wt.%, preferably more than 90 wt.%, preferably more than 92 wt.%, preferably more than 94 wt.%, preferably more than 96 wt.%, and less than 98 wt.%. [15] Preparation according to any of the preceding claims characterized by , that the weight ratio of the water phase to the oil phase is in the range of 4 to 1 to 2 to 3, advantageously from 7 to 3 to 1 to 1.4, and in particular from 1.2 to 1 to 1 to 1.2.